Publications by authors named "Song Guohong"

Claim this Profile
E
Extracellular vesicle miRNA detection based on membrane fusion and nucleic acid nanostructures.
Jixuan Han, Xiaoran Liu, Ying Yan, Jingwen Ge, Han Zhao, Guohong Song

Biosens Bioelectron· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of everolimus in patients with hormone receptor positive breast cancer: a real-world analysis.
Xinyu Gui, Yuhong Liu, Ying Yan, Lijun Di, Guohong Song

Future Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of [Ga]Ga-RM2 positron emission tomography imaging on staging and prognosis in estrogen receptor-positive breast cancer: A pilot study.
Jin Ding, Huan Ma, Xiaoyi Guo, Futao Liu, Qing Xie, Guohong Song

Chin J Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AlF-NOTA-HER2-BCH versus F-FDG PET/CT in evaluating newly diagnosed HER2-low breast cancer patients.
Xiaoyi Guo, Xu Liang, Ben Li, Yan Mao, Nina Zhou, Guohong Song

Eur J Nucl Med Mol Imaging· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival outcomes and subtype variations between primary breast cancer and liver metastases in 542 patients with advanced breast cancer: insights from a real-world analysis.
Ying Yan, Xinyu Gui, Lijun Di, Hanfang Jiang, Xu Liang, Guohong Song

Discov Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of first-line treatment with HLX02 versus reference trastuzumab plus pertuzumab in HER2-positive metastatic breast cancer.
Ying Yan, Ruyan Zhang, Yanling Li, Lijun Di, Xinyu Gui, Guohong Song

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Analysis of Oncogenic Somatic Alterations of Mismatch Repair Gene in Breast Cancer Patients.
Yin Yan, Yang Wang, Junjie Tang, Xiaoran Liu, Jichuan Wang, Guohong Song

Bioengineering (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of case-based learning and traditional teaching methods in advanced breast cancer education for oncology residents in the standardized training.
Xinyu Gui, Anjie Zhu, Guohong Song, Huiping Li

Biochem Mol Biol Educ· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HER2-targeted PET/CT imaging in patients with breast cancer and therapeutic response monitoring.
Xinyu Gui, Xu Liang, Xiaoyi Guo, Zhi Yang, Guohong Song

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering the Differed Susceptibility of ( and ) to Fungicide Phenamacril: From Computational and Experimental Perspectives.
Yiqiong Bao, Fangying Jia, Yiming Geng, Guohong Song, Ran Xu

J Agric Food Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study.
Jiaxuan Liu, Jiayang Zhang, Huiping Li, Guohong Song, Lijun Di

BMC Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study.
Yifei Chen, Ruyan Zhang, Ying Yan, Huiping Li, Guohong Song

Breast Cancer Res Treat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 status results in an unstable switch from primary to recurrent breast cancer.
Anjie Zhu, Nan Wang, Zehui Yun, Xiaoran Liu, Xu Liang, Guohong Song

Neoplasma· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study.
Ruyan Zhang, Xiaoran Liu, Guohong Song, Yan Zhang, Huiping Li

Cancer Res Treat· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the Mechanism of Phenamacril Resistance in : Computational and Experimental Insights into the C423A Mutation in FgMyoI.
Yiqiong Bao, Fangying Jia, Yun Lin, Guohong Song, Mengrong Li

J Agric Food Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of an Affibody-based Molecular Probe and F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT.
Xiaoyi Guo, Nina Zhou, Jiayue Liu, Jin Ding, Teli Liu, Guohong Song

Radiology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China.
Hanfang Jiang, Jianxin Zhong, Jing Wang, Guohong Song, Lijun Di

Cancer Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis.
Xu Liang, Linhui Zhang, Xinyu Gui, Lijun Di, Huiping Li, Guohong Song

Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcome Analysis of Pyrotinib in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: A Real-World Study.
Xu Liang, Xinyu Gui, Ying Yan, Lijun Di, Xiaoran Liu, Guohong Song

Oncologist· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study.
Yaxin Liu, Guohong Song, Lijun Di, Hanfang Jiang, Ran Ran

Oncologist· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition).
Bu Hong, Fan Ying, Fan Zhaoqing, Hu Xichun, Li Man, Song Guohong

J Natl Cancer Cent· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors.
Bin Zhang, Jianyi Zhao, Yongzhi Wang, Hua Xu, B O Gao, Guohong Song

Oncol Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of renal clearance of [F]AlF-RESCA-HER2-BCH and [F]AlF-NOTA-HER2-BCH in mice and breast cancer patients.
Jiayue Liu, Xiaoyi Guo, Li Wen, Lixin Wang, Futao Liu, Guohong Song

Eur J Nucl Med Mol Imaging· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting.
Ruyan Zhang, Yifei Chen, Xiaoran Liu, Xinyu Gui, Anjie Zhu, Guohong Song

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.
Yan-Gao Man, Ciaran Mannion, Alexander Stojadinovic, George E Peoples, William Cs Cho, Guohong Song

J Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis